Filters
reset allOther countries
Results: 1 to 12 of 12
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
Invitae Macular Dystrophy Panel Invitae United States | 66 | 36 |
|
Invitae Inherited Retinal Disorders Panel Invitae United States | 486 | 293 |
|
Stargardt Disease (STGD) and Macular Dystrophies Panel PreventionGenetics, part of Exact Sciences United States | 35 | 28 |
|
Baylor Genetics United States | 842 | 637 |
|
Sorsby Fundus Dystrophy via the TIMP3 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Retinopathy and Optic Atrophy NGS Panel Fulgent Genetics United States | 563 | 241 |
|
Neurotransmitter Metabolism Deficiency NGS Panel Fulgent Genetics United States | 85 | 101 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Comprehensive Eye Disorders NGS Panel Fulgent Genetics United States | 1018 | 459 |
|
Results: 1 to 12 of 12
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.